Who Are the Most Influential People in Vaccines? Blogs.Terrapinn.Com

Home , Craig Venter, George Siber, Paul Offit

blogs.terrapinn.com/blogs.terrapinn.com/vaccinenationvaccinenation /

Who are the most influential people in vaccines? blogs.terrapinn.com/

TOP 50 vaccine influencers vaccinenation Who are the most influential people in the global vaccines world?

This is the question we asked our blog subscribers, LinkedIn group members and anyone in our contact network to compile a comprehensive list of the Top 50 as named by you.

The following 50 personalities were picked based on their career achievements whether this was groundbreaking discovery and research or innovation, funding, lifetime dedication or simply because they might have inspired others to do well. It is great to see that we have representatives from all aspects including industry, governments, philanthropy, academia and even showbiz.

Thank you to everyone who has helped us compile the list and please feel free to share it with your colleagues. blogs.terrapinn.com/terrapinn.com/loyaltyasiavaccinenation in in

held held

Dubovsky MedImmune , Dr.

joined joined

, influenza influenza Prior franchise.

48 MedImmune No. 48 No. Dubovsky

President Clinical Development Clinical President Filip Dubovsky

- vaccine clinical development clinical development vaccine programs for clinical activities the vaccine and MedImmune's joining to responsibility increasing roles of several in Initiative, Vaccine the Malaria of support PATH. Dr. Dr. clinical director, as 2006 August vice named development was and development, clinical and president, vaccines head, clinical therapeutic global he the leads this capacity, In July 2008. in Filip Vice Disease, Infectious and Vaccines MedImmune

, at the White House. White the at No. 49 No.

Biodefense responsible twothe top foundation’s responsible for new and polio priorities of eradication and investments introduction, of vaccine million/year. Dr. $500 approximately previously was the Special Venkayya Senior the and President Director to Assistant for Rajeev Venkayya Rajeev Vaccine Vice President, Executive Division,Business Takeda Venkayya Vice President, the Executive is Dr. Pharmaceuticals Takeda at Business Vaccine overseeing global Takeda’s International, the he was this to Prior enterprise vaccine Bill Delivery the Vaccine & ofat Director he was Foundation, where Melinda Gates - to -

No. 50 No. 50 UNICEF Ambassador

. reach children children following in twothe world, reach by supported 'cold chains', or trails, vaccine Unicef Ewan McGregor is on a mission to the ends ofmission the ends is on a toMcGregor Ewan immunise to earth the hardest ofsome the Ewan McGregor, Ewan and Actor TOP 50 vaccine influencers 50 vaccine TOP blogs.terrapinn.com/terrapinn.com/loyaltyasiavaccinenation IV), - ),

) as lead physician )lead physician as

Pharmacovigilance

45 No. 48 No. Compiance (CMO) for Biologicals and regional and Biologicals regional for(CMO) activities. Affairs Medical Accountable for Department 1200 Department of for Accountable I (phase covering people, Clinical R&D Epidemiology Safety & Health Economics, Person (Qualified (including activities Governance Medical Medical Thomas Breuer, Thomas Head of Vice President, Senior Development Vaccine Global Biologicals GSK

has over 25 years experience experience years over 25 has No. 49 No.

Morgon Morgon General Manager and VP Global Marketing Global VPMarketing and Manager General Operations. global positions, local and these he Through experience direct with acquired has in diverse products markets blockbuster hospital, care, specialty care, (primary many biotechnology) and and vaccines, geographies. Pierre Pierre & Global Franchise President, Vice Strategy Marketing Pasteur Sanofi Pierre industry, in the pharmaceutical marketing in Product positions operations as and Product Group International Manager, International Marketing Director, Manager, Unit, Marketing, Business President VP Vice

No. 50 No. 47 technical advisor for PAHO’s immunization PAHO’s immunization for advisor technical advocateforceful been he a has where program, spreading vaccination. the ofbenefits for director of the Pan American American Health Pan of the director the Americas Regional Office for Organization, (PAHO/WHO). Health Organization the World of been serving Andrus lead senior has as Dr. Dr. Jon Kim Andrus, Jon Kim Andrus, public expert with health a Dr. working experience ofin of the field years of 25 in immunization, primary care and vaccines, deputy been named has countries, developing Pan American Health Organization American Pan Jon Kim Andrus, Unit Immunization Chief, TOP 50 vaccine influencers 50 vaccine TOP blogs.terrapinn.com/terrapinn.com/loyaltyasiavaccinenation

leads the Sabin Vaccine the Sabin leads

, 42

No. 48 No. Hotez for Vaccine Development Development at Vaccine based for

Hotez of neglected the neglected around diseases tropical of studies increase well to as as globe, the neglected tropical about awareness in developing diseases in and countries United States. the Dr. Peter Peter Dr. Children’s Texas Hospital and Institute Center Medicine College in of Baylor the focuses research academic His Houston. range development vaccine wide on a for Peter Peter President, Institute Vaccine Sabin

class class - was the the was

Sadoff was the Executive the Executive was

Dr. Dr.

Sadoff

, developed developed world's the

Dr. Dr. No. 49 No. Crucell

43 Sadoff

Sadoff jAeras Global TB Vaccine Foundation. While Foundation. at Vaccine TB Global Dr. , being tested in Africa in Phase IIB efficacy IIB tested in in being Phase Africa development of network built strong a trials, world a created and partnerships, infrastructure. manufacturing vaccine to Prior Development Clinical of of Vaccines Director Merck. at Jerald Jerald Officer, Medical Chief Crucell joining Before Executive and Officer ofChief President Aeras Aeras candidates, vaccine TBleading portfolio of currently four candidates of the two with -

Okwo

Bele - is responsible responsible for is

Bele

- Okwo

No. 50 No. 44 Okwo Marie Marie - Marie Marie -

worked at country, regional and regional global country, at worked

. immunization programmes, contributing immunization toprogrammes, contributing building, formulation, policy capacity and evaluation, planning and programme surveillance. disease During his 27 years in public in public Dr years health, his 27 During Bele childhood levels the ofexpansion in of support Dr Jean Dr direction, and coordination strategic normative and ofprogrammatic management immunization activities. and Biologicals, and WHO Dr Jean Dr Vaccines ofImmunization, Director TOP 50 vaccine influencers 50 vaccine TOP blogs.terrapinn.com/terrapinn.com/loyaltyasiavaccinenation

led led the

going togoing efforts - Gerberding

, leads the company's leads

led the agency during during more led agency the

Gerberding for Disease and Control Disease for

Gerberding accelerating Merck's Merck's on accelerating in the vaccines to its access broaden developing Dr. world. Centers to from 2002 director as (CDC) Prevention Dr. CDC, During her tenure at 2009. Gerberding emergency response initiatives. 40 than Dr. Julie Julie Dr. billion business. global is $5 vaccine She ofthe commercialization responsible for planning vaccines, portfolio of current the from the the introduction vaccines of for pipeline, vaccine robust and company's Julie President, Vaccines Merck

for

Center

for Global Global Health for

Center , , MD, MPH, is Senior Senior MPH, is ,Advisor MD, No. 49 No. for Global Health (CGH) for

40 Cochi Cochi Center Immunization and Respiratory Diseases. Respiratory Immunization and Stephen Stephen Director, to theAdvisor Senior CDC L. Stephen CDC the Director, to Immunization the Global on and (CGH), continuing his in Initiative, addition to Health Global Advisor Senior the Director, as to role Immunization Division, National P.

)

No. 50 No.

ISGlobal 41 . He has published published has He than more 200 .

falciparum in peer international reviewed papers journals. Some of his most relevant work has been been has workhis most relevant ofSome the out in leading malaria, to carried control new of testing and development ofthe prevention treatment for ortools of morbidity morbidity most mortality of and in the two vulnerable population in groups Africa: children pregnant women. young and Dr. Pedro Alonso started his career in in career his started Alonso Pedro Dr. a as ago years 25 Health International then Since Africa. West working in physician in the key focused determinants has work his Institute for Global Health offor Institute ( Barcelona Pedro Alonso, Pedro Director, TOP 50 vaccine influencers 50 vaccine TOP blogs.terrapinn.com/terrapinn.com/loyaltyasiavaccinenation

has been been has

level level WHO - had served served in had

Vandelaer leads strategy strategy leads

, Vandelaer

has served as a Senior Senior a served as has

Vandelaer

Jos Vandelaer Vandelaer

Health Specialist as a Global a Specialist as Health Tetanus the Neonatal point for focal advised also He on Elimination program. included immunization that policy issues development, provided strategy and and advice. scientific Dr. that, to Prior a Medical Officer in India, as WHO Philippines, Myanmar. and Dr. Dr. management development program and Dr. coordination. and in immunization working 1996. since Dr. Jos of Immunization, Chief UNICEF

Canada in in Canada

Frosst

No. 49 No. 37

He has spent 30 years at Merck, starting in starting Merck, at years 30 spent has He Tony moved Pennsylvania to to 1998, In head the basic research effort in in effort the and USA research basic the head As covering all areas. therapeutic worldwide, he Vice President became Executive an in strategies franchise responsible for including multiple Vaccines disease areas, Infectious Diseases. and Anthony Ford Hutchinson, Ford Anthony Vice President, Executive (ex) Merck he joined Merck when 1981 moving years 17 he spent where Montreal, Vice to Senior Pharmacology of Director from and Head. Site President

) , Fiocruz (

chair chair -

chair of the Bill & Melinda Melinda Bill & the of chair No. 50 No. - strategies, advocates for the for the advocates strategies,

38 expand opportunity mostthe opportunity world’s toexpand people collaborating with disadvantaged by partners. and grantees foundation’s issues, and helps overall helps set issues, the and foundation’s the organization. ofdirection to together work and Melinda Bill Gates Bill Gates is is co Gates Bill Along Foundation. co with Gates approves and he shapes Melinda Gates, grantmaking Oswaldo Cruz Foundation CruzFoundation Oswaldo Paulo Ernani Gadelha Vieira Paulo President, TOP 50 vaccine influencers 50 vaccine TOP blogs.terrapinn.com/terrapinn.com/loyaltyasiavaccinenation

is an internationally internationally an is

, 33

Koff twice by the United by the United States twice

Koff Award for developing developing for innovative Award the development accelerate to strategies oversees He IAVI’s AIDS vaccines. of research, in AIDS vaccine programs development. and discovery Prior to between Wayne 1992 served IAVI,joining vice president, as Vaccine 1998 and Development United and at Research he was where Inc.,Biomedical, program. R&D vaccine the for responsible Wayne C. Wayne in leader AIDS vaccine recognized development. and been has He research honored and Human Health of Department Service of Special Act the with Services Wayne Wayne CSO, and Vice President Senior AIDS Vaccine International Initiative

. Elias currently . currently Elias serves on No. 49 No. 34

behaviors president and CEO of PATH, dedicated dedicated toPATH, of and CEOpresident improving people ofthe the health around technologies, advancing by world encouraging strengthening and systems, healthy including boards, advisory various the Nike Health Global Duke the and Foundation Institute. Christopher Elias, Christopher Global Development, President, Foundation Bill & Melinda Gates the efforts foundation’s leads Elias Chris Dr. and innovative integrated in delivery, finding solutions ensure toand ways new creative people of in hands into get the products need developing them most.who countries the most recently Elias served as Dr.

was the the was

Loucq

Biotech and and Biotech

, Rhein

No. 50 No. 35 Loucq has over 30 years of professional professional of years 30 over has

. Most recently, Dr. . Most recently, Loucq based at PATH in in the U.S. PATH at based companies such as such companies Acambis Initiative Vaccine Malaria the of Director product development a (MVI),partnership in China, India and Thailand, and worked with with worked Thailand, and India and China, in GlaxoSmithKline as companies such vaccine biotechnology and Pasteur, Sanofi and Dr. Dr. in medicine, experience vaccines, and globally. global health pharmaceuticals, businesses vaccine addition, managed he In International Vaccine Institute Vaccine International Christian General, Director TOP 50 vaccine influencers 50 vaccine TOP blogs.terrapinn.com/terrapinn.com/loyaltyasiavaccinenation

Center

He leads the leads He

cell immunology, immunology, cell -

and HIV vaccine vaccine HIVand

. He is the Director of the Duke Duke the of the Director . He is Immunology at Duke University Duke University Immunology at Medical Center the Institute and Vaccine Human Immunology Vaccine HIV/AIDS (CHAVI) for in 2005. by the NIAID funded as Consortia Discovery Vaccine Haynes Vaccine AIDS forthe Collaboration of part (CAVD) funded by the Bill Discovery and Foundation in 2006. Melinda Gates Barton Ford Haynes is a U.S. physician physician U.S. and a Haynes is Ford Barton immunologist internationally is and in T work for recognized retrovirology Frederic M. development. is a Haynes of Medicine Professor and Hanes Barton Haynes, Barton HumanVaccine ofthe Director , Institute School of Medicine University Duke

for Biologics Biologics for

varicella

, Center No. 49 No. (HPV), influenza, influenza, and (HPV),Zoster

31 pertussis

acellular Deputy Director of OVRR and Associate Associate OVRRand of Director Deputy has He Regulatory Policy. for Director the development facilitated and evaluated such licensure numerous vaccines new of and as human conjugate, pneumococcal papillomavirus generation combination new of the all FDA. at career year during his 20 vaccines Norman Baylor, Norman & CEO, President Biologics Consulting Group formerly the was Baylor W. Norman Dr. Research of Vaccines the Office of Director Drug Review in (OVRR)the and Food and Administration’s his Prior to and Research. Evaluation Baylor served as Dr. Director, position as

No. 50 No. 32 Balasegaram

in the field to identify the field identify in to workthe problems and them. overcome to vaccines that aren’t ideal or suited suited the or ideal to aren’t that vaccines they environments live. where Access MSF’s with teams MSF to work continues Campaign over a decade now.decade a over medical on still and our teams years Over ten same kind medical the challenges of face and people in treating daily, tests drugs, with MSF’s Access Campaign has been been has working to Campaign Access MSF’s to get access MSF medical teams help and effective medicines, suited toaffordable well for operate, we where environments the MSF Access Campaign Access MSF Manica Director, Executive TOP 50 vaccine influencers 50 vaccine TOP blogs.terrapinn.com/terrapinn.com/loyaltyasiavaccinenation

Siber

®. Prior to Wyeth, Wyeth, Dr. Prior to ®.

used used childhood vaccines, , - 27

Prevnar Siber , Executive most recently Vice was Director of the Massachusetts the Massachusetts of Director was

Siber including including Siber a and Health Biologic Laboratories Public Medical Associate School Harvard Farber Medicine of at Dana Professor Institute. Cancer Dr. Dr. Scientific and Officer ofChief President leading a authority on is Vaccines, Wyeth Dr. at Wyeth, While vaccines. the development of approval oversaw and multiple widely George George Chairman, Executive Genocea

is the CEO and Director of Director and CEOis the

No. 49 No. 28

In parallel with researchers at the the at parallel researchers In with

patented the basic technology behind technology behind the basic the patented the cancer; cervical against vaccine HPV preventing the and cancer vaccine, second designed vaccine prevent a cancer. to first Ian Frazer, Ian ofResearch, & Director CEO Institute Research Translational Frazer Hector Ian Research the Translational of Research Institute. Institute, Georgetown Cancer National University University, and Rochester, of his developed and colleagues and Frazer

, combination , combination

, , recently retired Vice as recently retired , vaccines, especially especially in vaccines, the No. 50 No.

29 has published in the published broadly has

glycoconjugates Paradiso Paradiso

pediatric Paradiso . areas of areas viral respiratory vaccines. and vaccines development. in the field development. worked of has He years. development 28 vaccine the past for Dr offield scientific affairs and strategic planning planning within strategic and affairs scientific development and research group vaccine the commercial in oversight forof products and Peter R. Peter Affairs and Business Scientific New President, Division this Pfizer. In a of Pfizer Vaccines, for responsible global for he was position, and Scientific Affairs, Scientific and Pfizer Peter Peter New Business President, Vice (ex) TOP 50 vaccine influencers 50 vaccine TOP blogs.terrapinn.com/terrapinn.com/loyaltyasiavaccinenation

Foege

for Disease Disease for

Centers

, is an epidemiologist is epidemiologist an who

24 Foege Foege director of CDC in in 1977. of CDC director William William H. to campaign in the successful worked Dr. smallpox 1970s. in the eradicate the Chief of became Prevention Smallpox and (CDC) Control appointed and was Program, Eradication William Epidemiologist - of -

a state

– and and

No. 49 No.

25 Immunovirology

Chief journal Chief for“Vaccine.” the - in - art research group and laboratory that laboratory that group and research art - Professor of Medicine Medicine of and Infectious Professor the Immunization of the Director Diseases, in the Program of the Director and Clinic Translational the the Mayo Clinic. is He at Biodefense Editor Gregory Poland, Gregory Director, Clinic Mayo Mayo of the Director is Gregory Poland Dr. Group Research Vaccine Clinic’s the surrounding issues vaccine investigates policy, novel and vaccine vaccines response, a is public Poland health. to Dr. important

No. 50 No.

and Professor of International Health at the the Health at of International Professor and Hopkins Bloomberg Public Johns ofSchool Health. with the GAVI Alliance, whose mission mission Alliance, is the GAVI whose with children’s to lives saving by access increasing countries. poor in immunization IVAC of Director Executive he was that Before and related improve related to technologies and and immunization routine is He systems. the engagement point for focalFoundation’s Dr. Orin Levine is Director of Vaccine Delivery Delivery Vaccine of Orin Levine Director is Dr. Melinda the Bill Foundation, and Gates at to the he Foundation’s leads efforts where vaccines the introduction new of accelerate Bill & Melinda Gates Foundation Bill & Melinda Gates Orin Levine, Orin Delivery, ofVaccine Director TOP 50 vaccine influencers 50 vaccine TOP blogs.terrapinn.com/terrapinn.com/loyaltyasiavaccinenation

Sanaria

genome genome and

malaria vaccine. From From vaccine. malaria

falciparum 21

sporozoite 2001 he was Director of the the Malaria of Director was he 2001 - Center where he and his were his team he and where Center sequencing in the the ofleaders Plasmodium first in studies the world the conducted elicited vaccines DNA that showed that killer cells in humans. T Dr Hoffman is the Founder, Chief the Founder, is and Hoffman Dr Officer and of Scientific Executive to developing company dedicated a a Inc., whole 1987 Medical Research the Naval at Program Stephen Hoffman, Stephen CSO, & CEO Founder, Sanaria

, profit profit -

profit and non and profit -

, vaccine technologies technologies and vaccine - No. 49 No. directs the identification identification the ofdirects 22

blocking blocking program (TBV)vaccine - Birkett Birkett

to leading he MVI’sleads leading Unit, the R&D to transmission the on development focused malaria of transmission to malaria reduce that vaccines elimination future support efforts. Ashley Ashley MalariaVaccine R&D, Director PATH Ashley promising malaria implementation of development for with partnerships in alignment MVI’s research with partners development addition In strategy. and (R&D)

, both as a scientist , scientist and as a both , is an immunologist immunologist has an is who

No. 50 No. 23 Fauci

Fauci

treat infectious diseases as HIV/AIDS such diseases infectious treat other sexually infections, transmitted and illness and malaria tuberculosis, influenza, bioterrorism. of agents potential from as the head of the NIAID. He oversees oversees He an the NIAID. the ofhead as and portfolio basic ofresearch extensive prevent, diagnose, to and applied research Anthony S. Anthony in research contributions to substantial made other and HIV/AIDS of areas the immunodeficiencies NIAID Anthony Anthony Director, TOP 50 vaccine influencers 50 vaccine TOP blogs.terrapinn.com/terrapinn.com/loyaltyasiavaccinenation ,

Wavre , and , and

. Lambert Lambert BioWin

Biocapital Bruxelles

was until until recently was

18 Groupe Stéphenne Stéphenne Chairman of BESIX, IBA and and IBA of BESIX, Chairman Fortis, Paribas BNP of Director as VBO/FEB, Vesalius and (GBL), Jean Jean Executive Team the Corporate ofMember Chairman GlaxoSmithKline and (GSK), of in Biologicals GSK President of and he built which Belgium, world into a as He currently serves in vaccines. leader Jean Jean President, and Chairman (ex) Biologicals GSK

No. 49 No. 19 profit, research organization with with organization research profit, - for - approximately 300 scientists and scientists staff 300 approximately human, microbial, toplant, dedicated environmental and synthetic genomic and the exploration social ofand research, in issues genomics. ethical Craig Venter, Craig & CEO, Chairman Founder, Institute Venter Craig J one of regarded as is Venter, Ph.D., Craig J. for century the 21st leading ofscientists the numerous invaluable his contributions to Chairman, is He Founder, research. genomic Venter Institute (JCVI), Craig the J. ofCEO and not a

, Sanofi which and joined joined and

, Genzyme

No. 50 No. 20

Viehbacher

Europe, in the United States and in in Canada. and in the United States Europe, GlaxoSmithKline (GSK) in 1988. Throughout Throughout in 1988. GlaxoSmithKline (GSK) company, he the years with 20 next the international broad experience in acquired also Chairman of Chairman also in February 2011. acquired in finance at his career started Christopher PriceWaterhouseCoopers Since December 2008, he has held held the he has 2008, December Since and Officer, Sanofi Chief Executive position of member, in being addition Board to a a is is He Committee. Strategy the of member Sanofi Chris CEO, TOP 50 vaccine influencers 50 vaccine TOP blogs.terrapinn.com/terrapinn.com/loyaltyasiavaccinenation

& Byers Byers and &

, Caufield Inc, where he is engaged engaged where he is Inc, AG and Chief and Chief Technical AG

is also a Venture Partner a Venture is also

15 is Chief Chief Medical is Officer of

Perkins Perkins PaxVax Monath

BioTech

Monath Monath Kleiner development, development, preclinical manufacturing, clinical development, and regulatory and affairs. at ofSchool Harvard Professor, Adjunct Health. Public Dr. Dr. Hookipa of Officer His vaccines. development new in of experience across cut and expertise analytical and process research, discovery Thomas Professor, Adjunct School of Public Health Harvard

16 Group of Experts on Vaccines from 2005 to from 2005 on Vaccines Experts of Group European Region of the is Chairman 2010, Poliomyelitis Commission for Certification member Polio is ofa and Eradication, Commission Elimination twoCertification for WHO regions. further David Salisbury, David ofImmunisation, Director Health of UK Department David is Salisbury responsible forProfessor immunisation national the programme. responsibilities, addition his UK to he In the on WHO the extensively with works wasHe Vaccines. for Programme Global Advisory WHOof the Strategic Chairman

as interim interim as

VaxInnate

No. 50 No. 17

leading leading worldwide role in the

as Vice President, Marketing Vice President, in U.S. as , the largest company entirely company entirely largest , the pasteur’s approximately with market vaccine influenza global sales. of percent 50 responsibility responsibility including Global of Head Operations Corporate and Commercial sanofi credited with is Wayne Strategy. pasteur joined sanofi Wayne vaccines. to dedicated pasteur held and positions increasing of 1997 Wayne Pisano joined joined Pisano Wayne and 2012 Officer Executive in January Chief is Wayne in permanent April CEO2012. as sanofi of CEO and President former the Vaxinnate Wayne Pisano, Wayne & CEO, President TOP 50 vaccine influencers 50 vaccine TOP blogs.terrapinn.com/terrapinn.com/loyaltyasiavaccinenation , and

Center

12 at Emory University, University, associate Emory at

pediatrics foundation had been been on polio had foundation eradication, improving and control, measles routine and 2004 immunization Between programs. medicine of professor and he was 2008, pediatrics Emoryof the Vaccine director on Vaccine Emoryof the Program director Development and other Policyamong responsibilities. Walter Orenstein, Walter ofmedicine,globalhealth, Professor and University Emory Orenstein was Dr. 2011, through 2008 From Immunization Programs director fordeputy Delivery the Department of the Vaccine in the Bill Melinda at & Program Health Global the primary His at Foundation. focus Gates at the the at

Pathobiology

University of Washington. He serves serves He Washington. on University of editorial review committees, several has member the Tropical Medicine ofa as served of Institutes National of the Board Review member Vaccine a ofand the is Health, Development Steering Committee of the Health Organization. World Steven Reed, Steven & Founder, President IDRI Reed is President, and the Founder, Steve Research Disease the Infectious of CSO appointments His academic (IDRI). Institute Medicine Cornell of at include Professor and YorkUniversity Medical College in New of Professor Research

generation vaccine generation

- joined joined Wyeth as

, No. 50 No. Emini

, Ph.D., is Senior , Senior Vice is Ph.D., 14 Emini Emini

and Development At Development in and November 2005. resulted that led efforts R&D he the Wyeth, second our licensure of in the prevention disease. pneumococcal offor Pfizer's acquisition Wyeth acquisition Pharmaceuticals of Pfizer's Dr. 2009. late in Research Viceof President Vaccine Executive Emilio A. A. Emilio Scientific and Officer ofChief President position a Inc., Pfizer at Research Vaccine he transitioned subsequent which tointo Scientific Officer Vaccine Research, Vaccine Officer Scientific Pfizer Emilio Chief and Vice President Senior TOP 50 vaccine influencers 50 vaccine TOP blogs.terrapinn.com/terrapinn.com/loyaltyasiavaccinenation

, 9 Quadros was the Director of the Division the Division ofthe Director of was

de de

Chief Epidemiologist Epidemiologist Chief the Smallpox for Ethiopia Programfrom in 1970 Eradication 1976. to Ciro of Director Vice President, Executive Education and Advocacy Vaccine Institute Vaccine Sabin de Dr. in 2003, joining Sabin Before Quadros Immunization the Pan and at Vaccines He also Health Organization. American Health Organization's the World as served

Trust Sanger Institute Sanger Trust 10

Dougan College. He represents of represents College. He the area

studies enteric pathogens with a strong strong a with enteric pathogens studies mechanisms pathogenic on basic emphasis immunology and is and involved he in the running Programme Genetic an Mouse in screen novel strains. infection KO Gordon of oftheBoard Member Management, Wellcome at Professor Honoraryan is also He Fellow University of a Cambridge and Wolfson of Board on the WTSI Pathogens team research personal His Management.

chikungunya

He provided provided He

emerging emerging infectious -

No. 50 No.

, 11 joined Sanofi as chief scientific scientific chief as joined Sanofi

Nabel Nabel and other viruses. other viruses. and of novel vaccine strategies against HIV and and HIV against novel strategies ofvaccine emerging re other and Ebola/Marburg including diseases, fevers, influenza, hemorrhagic overall direction and scientific leadership leadership direction scientific overall and of research translational clinical, and basic, the guided and VRCdevelopment of the activities Dr previously having in 2012, November officer research vaccine of the director as served the NIAID. of (VRC) centre Scientific Advisory Council,Advisory Scientific Sanofi Gary Gary and Development Strategic Chair, TOP 50 vaccine influencers 50 vaccine TOP blogs.terrapinn.com/terrapinn.com/loyaltyasiavaccinenation

Center

pediatrician inventor of a rotavirus a rotavirus of inventor - 6

, is an American American is an

Offit Offit hundreds lives of hundreds every day. Paul Paul Education Vaccine Director, Hospital Philadelphiaof Children's A. Paul an and in specializing diseases infectious immunology, vaccines, on expert and He is virology. the co been saving credited has with that vaccine

, besides member besides a ,

7 , is associated with the the with associated is

FastVac Jadhav Jadhav Protection & Synergies Synergies etc. & Protection Group

currently a member of GAVI Board, EVI Board EVI member Board, GAVI ofa currently Stakeholders, of & Policy Committee GAVI. ofthe Program of advisory various with associated is also He Sabin Vaccine of Force committees/Task Vaccines of Decades and IVRWHO Institute, – Suresh Suresh Director, Executive India Institute Serum largest the of is one India of Institute Serum from the developing manufacturers vaccine affordable supplying at countries, vaccines Dr. prices. is He its since inception in 2000. DCVM

as its its as

, the the ,

Bianco

Bianco at the the Liverpool at

departs. departs.

8 No. 50 No. of filarial infections. filarial infections. of The

, Trust Walport

Parasitology joined the Trust in 1999 as Head Head as in 1999 Trust the joined

Trust, appointed appointed Ted Trust,

Bianco Bianco take the helm on 14 March, when current when current March, the helm 14 on take Mark director immunobiology Wellcome 2013. in Feb director acting technology will of director transfer, charity’s Professor of Professor Medicine Tropical where he ofled a School the group working on research Ted Ted Initiatives and and the department Centres of in Technology ofTransfer Director became the joining Before was Ted the Trust, 2002. Wellcome Ted Ted Director, Acting TOP 50 vaccine influencers 50 vaccine TOP blogs.terrapinn.com/terrapinn.com/loyaltyasiavaccinenation

where he served as the Ministry of Health as heservedthe Ministry where

for Disease Control and the Task Force for Child for Force theTask and Disease Control for

Center

Uganda.

Centers Seth Berkley, Seth CEO, Alliance GAVI such as the G8, EU and the UN. He also oversaw the creation of such G8, creation as thethethe UN. EU He and also oversaw

fora 5 Epidemiologist in Epidemiologist work at the U.S. theU.S. at work theCarter at Survival Sciences Division at The Rockefeller Foundation where hemanaged where Foundation Theat Rockefeller Sciences Division healthpublicand health AIDS, reproductive onvaccines, programmes also includesAmerica. His experience past Asia Africa, andin Latin training and developing country scientists. country developing and of Health the officer an was in1996, Berkley Dr IAVI founding to Prior political political academia, industry, involving effort development product vaccine virtuala and fundraiser and a proven ability in building coalitions around a common coalitions around buildingin ability a proven and fundraiser and programme a globaladvocacy implemented IAVI his Underleadership, vision. inthein media and attention prominent receive vaccines that assured that Vaccine Initiative. Vaccine CEO as entrepreneurial an ofexperience a wealth GAVI to brings Berkley Dr CEO of the GAVI Alliance and a global advocate on the power of vaccines. He He of vaccines. power onthe Alliancea globaladvocate and oftheGAVI CEO AIDS ofInternational theCEO and President former and also is founder the Seth Franklin Berkley, M.D. is a medical epidemiologist by training. He He is the training. byis epidemiologistmedical a M.D. Berkley, Franklin Seth TOP 50 vaccine influencers 50 vaccine TOP blogs.terrapinn.com/terrapinn.com/loyaltyasiavaccinenation

governmental organizations, organizations, governmental -

range effects of childhood illnesses hinder theillnesses childhoodof hinder effects range quality vaccines requires a comprehensive a comprehensive vaccines requires quality - -

Chair and Trustee, Trustee, and Chair - controlled delivery system called the "cold chain." Vaccines Vaccines chain." the"cold called system delivery controlled Bill & Melinda Gates Foundation Gates Melinda & Bill Melinda Gates, Melinda Co effective vaccines to the people who need them is complicated. thethemwho people is needcomplicated. to vaccines effective - -

the coordinated efforts of national governments, their globaldevelopment their governments, ofnational efforts coordinated the non companies, pharmaceutical partners, parents. and workers, health community We believe that a coordinated effort to develop and distribute underused distribute and to develop effort coordinated a that believe We Success millionsthrough oflives. will save beachieved vaccines can new and difficult to ensure this type of transport from the airport to the children in children to the airportthe from of thistypetransport to ensure difficult vaccines. thewho needvillage the temperature themfrom prevent to temperature correct the at betransported to need it's countries, many in But heat. too much to exposed or being freezing either Getting cost Getting high delivering Successfully themselves or others. This puts a strain on their families and on theon and families theiron a strain putsThis or others. themselves countries. economies ofdeveloping availability of effective vaccines. Millions more survive, but they’re left left they’re but survive, Millionsmore vaccines. ofeffective availability Thelong impaired. severely for work, care or become educated, ofthose to who survive ability endorsing mass polio virus vaccinations in India.in mass vaccinations poliovirus endorsing thediseases despite preventable diefrom 2.4 millionchildren year, Every Melinda French Gates is an American businesswoman and philanthropist. philanthropist. andis businesswoman Gates American an French Melinda publicly andbacking is financially Foundation Gates Melinda and Bill The TOP 50 vaccine influencers 50 vaccine TOP blogs.terrapinn.com/terrapinn.com/loyaltyasiavaccinenation

Paul Paul

, C and later against against later C and and then head ofhead thenand

vaccine against against vaccine

influenzae meningococcus

H. H. Sclavo acellular

pertussis usedin

meningococcus

(1991), the Gold Medal by the Italian Italian (1991),the Goldbythe Medal , used in a vaccine against pandemic against a invaccine used CRM197

vaccines; vaccines; an

derived vaccine against vaccine derived MF59 -

Rappuoli the

pneumococcus ACYW;

Rino & Development, Research of Head Vaccines Novartis conjugate vaccine against against vaccine conjugate is Global Head of Vaccines Research at Novartis Vaccines and Vaccines Novartis at Research is GlobalHead ofVaccines

and

first

containing a genetically detoxified detoxified a genetically containing

the

Rappuoli

3 currently under review by European and Canadian regulatory agencies. regulatory Canadianand European by review under currently

Microbiology and Infectious Diseases (2011). Infectious and Microbiology President (2005), the Albert B. Sabin Gold Medal (2009), the Lifetime GoldMedal(2005),(2009), SabinLifetime B. theAlbert the President Marylandin ofHumanVirology the Institute from Award Achievement ofClinical Society European the from Award theExcellence and (2010), European Molecular Biology Organization. Awards conferred include: conferred Awards Biology Organization. Molecular European Prize Darmstaedter Ludwig and Ehrlich B ofSciences theand Academy memberofwas US National the He elected toxin; meningococcus genome theand influenza; meningitidis pertussis to becoming, near are or part, became with molecules heworked Several These vaccines. include:licensed Rockefeller University in New York and Harvard Medical School in Boston. Boston. Schoolin Medical Harvard and Newin York University Rockefeller of R&D headpositionhewas the present to Prior Corporation. ofChiron Officer Scientific Chief and research vaccine Diagnostics and is based in Siena, Italy. He earned his PhD in Biological PhD hisBiological He inearned is Siena,Italy. inand based Diagnostics at as servedscientist has ofSienaandvisiting University theSciences at Rino TOP 50 vaccine influencers 50 vaccine TOP blogs.terrapinn.com/terrapinn.com/loyaltyasiavaccinenation

, LLC. ,

Institute and at the same theat and Institute

Vaxconsult Wistar of Pennsylvania

and Microbiology at the University theUniversity at Microbiology and

Uni

, Pediatrics

Plotkin organizations as principal of as principal organizations Connaught, where for seven years he was Medical and Medical hewas years seven for where Connaught,

Adjunct Prof, Prof, Adjunct University Hopkins Johns Stan Stan Prof, Emeritus attended New York University, where he received a B.A. degree, hereceived where University, New York attended at the Children’s Hospital of Philadelphia and the Hospital for Sick for the Hospital and of Hospital Philadelphia Children’s the at

Mérieux for Disease Control of the US Public Health Service.oftheUS Public Health Disease Control for

- profit research research profit -

Plotkin 2 Centers internship at Cleveland Metropolitan General Hospital, residency in residency Hospital, General Metropolitan Cleveland at internship pediatrics Service ofthe EpidemicIntelligence thein years three andLondon in Children and then the State University of New York Medical School in Brooklyn, where where School Brooklyn, Medical in ofNew York University theState then and included career 1956. in His subsequent degree M.D. an received he non Dr. Pasteur He is Pasteur. is Sanofinamed Thenow same company Director. Scientific and companies biotechnology manufacturers, vaccine to consultant now time, Director of Infectious Diseases and Senior Physician at the Children’s Children’s the at Diseases SeniorPhysician and of Infectious Director time, vaccine jointhe to University the heleft Then ofPhiladelphia. Hospital Until 1991, he was Professor of 1991, Professor hewas Until theat of Virology Professor Pennsylvania, of TOP 50 vaccine influencers 50 vaccine TOP blogs.terrapinn.com/terrapinn.com/loyaltyasiavaccinenation

life. have access access to have — grant making grant

Chair and Trustee, and Chair -

Bill Gates, Bill Co Foundation Gates & Melinda Bill chair of the Bill & Melinda Gates Foundation. Along with Foundation. Gates & MelindaBill ofthechair

especially those with the fewest resources fewest thosethewith especially

— 1 chair Melinda Gates, he shapes and approves approves heshapesGates, and Melindachair - people school succeed in to and need they opportunities the and giving them the chance to lift themselves out of hunger and of themselves out hunger liftchancethem the to giving and foundation’s thein a role major played have Vaccines poverty. extreme all that seeks it to ensure States, theInUnited initiatives. supported Guided by the belief that every life has equal value, the Bill & MelindaBill the value, has equal life every that belief the by Guided productive healthy, peopleall leadto help works Foundation Gates health people’s onimproving focuses it countries, developingIn lives. partners. to the opportunity to expand work together Gates Melindaand Bill and grantees with collaborating bypeople disadvantaged most world’s co set the helps andissues, foundation’s the for advocates strategies, organization. ofthe direction overall Bill Gates is Gates co Bill TOP 50 vaccine influencers 50 vaccine TOP

blogs.terrapinn.com/ terrapinn.com/loyaltyasia We’d love to hear your views on all of this… vaccinenation

Join the conversation

Click here to leave a comment on this page on the Vaccine Nation blog Click here

Click here to contribute to our LinkedIn discussion Click here Click here to follow us on Twitter @vaccinenation Click here

Click here to sign up for the Vaccine Nation blog e-newsletter for more updates on strategy and Clickinnovation here in vaccines

terrapinn.com/vaccines We’d love to meet you terrapinn.com/loyaltyasia too…

The World Vaccine Congress & Expo is now in its 13th year. It is the world's biggest and most comprehensive event for the vaccine industry.

Over 60% of our attendees come from the world’s leading pharma and biotechs.

Our expo market place is the only one of its kind for the vaccine industry.

Combining a high level conference with a focused exhibition and adding in guaranteed meetings with targeted buyers in a 1-2-1 Partnering format makes this event the one must-attend event for the whole vaccine market.

To learn more about the World Vaccine Congress, visitClick the website. here

Be sure to check out our blog for more information about strategy and innovation in vaccines. terrapinn.com/vaccines